Smoking Cessation Support for Patients With Rheumatologic Diseases Via WhatsApp

Tobacco Use Cessation Clinical Trial

Official title:

The Effect of Supporting Routine Smoking Cessation Interventions With Whatsapp-mediated Motivational Information on Smoking Cessation Success in Active Smokers With Inflammatory Rheumatic Diseases: A Randomized Controlled Study

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT06219551
• Other study ID #: SCRW
• Status: Recruiting
• Phase: N/A
• Start date: November 10, 2023
• Est. completion date: November 30, 2024

Study information

• Verified date: January 2024
• Source: Recep Tayyip Erdogan University Training and Research Hospital
• Contact: Dilek Karadogan
• Phone: 5063512295
• Email: dilek.karadogan[@]erdogan.edu.tr
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Smoking cessation support for patients with rheumatologist diseases is an underestimated issue. In the previous prospective cohort study the investigators determined that with the brief cessation interventions 63.5% of smokers with rheumatologic diseases were willing to quit and the rest 36.4% were not willing. Among the willing group the highest quit rate was detected in the group that admitted to smoking cessation clinic. Therefore to increase the willingness to quit as well as to increase the Access to evidence based tobacco cessation support using new comminication technologies can be relevant. Investigators' aim in this study is to examine the effect of including WhatsApp in the routine smoking cessation practices on the quitting success of active smokers with rheumatic diseases who apply to the Rheumatology outpatient clinic.

Description:

In this randomized controlled study, the sample will be randomly divided to 2 arms. In one arm, usual care arm, smoker patients with rheumatologist diseases will be implemented brief smoking cessation interventions and referred to quit lines or smoking cessation services and also directly contacted to get an appointment from the cessation clinic. In the other arm, the intervention arm, smoker patients with rheumatologist diseases will be implemented brief tobacco cessation interventions and directly contacted to get an appointment from cessation clinic and will be send periodically motivational and informative text messages regarding tobacco cessation via WhatsApp.

Primary outcome measures will be the quit rate of both arms at 3rd, 6th and 12th month.

Secondary outcomes will be access to evidence based smoking cessation support, admission rate of smoking cessation clinic and treatment use duration of cessation medications.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 220
• Est. completion date: November 30, 2024
• Est. primary completion date: September 1, 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

1. Patients applying to the rheumatology outpatient clinic

2. Those aged 18 and over

3. Those who are active smokers

4. Those diagnosed with inflammatory rheumatic disease

5. Those who gave informed written consent to participate in the study

Exclusion Criteria:

1. Those with active psychiatric disease diagnoses such as psychosis, major depression, schizophrenia among their current diagnoses

2. Those with cognitive dysfunction

Related Conditions & MeSH terms

• Collagen Diseases
• Rheumatic Diseases
• Tobacco Use Cessation

Intervention

Other:
• Mobile messages via What's App
The information article that was prepared by taking the opinions of academics experienced in adult education, and were prepared as a video by the primary Rheumatologist who performs the randomization and will be shared in the Whatsapp group as information. Additionally, information will be provided once a week regarding the appointment date of the smoking cessation clinic.

Locations

Country	Name	City	State
Turkey	Recep Tayyip Erdogan University, Training and Research Hospital	Rize

Sponsors (1)

Lead Sponsor	Collaborator
Recep Tayyip Erdogan University Training and Research Hospital

Country where clinical trial is conducted

Turkey, 

References & Publications (1)

Cheung YT, Chan CH, Lai CK, Chan WF, Wang MP, Li HC, Chan SS, Lam TH. Using WhatsApp and Facebook Online Social Groups for Smoking Relapse Prevention for Recent Quitters: A Pilot Pragmatic Cluster Randomized Controlled Trial. J Med Internet Res. 2015 Oct — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Rate of participants with successful quit attempt	Successful quitter: sustained abstinence since the target quit date will be asked and validated by exhaled breath carbon monoxide measure.	3-6 and 12 months after the randomization
Secondary	Access to evidence based cessation support	Admitters to cessation clinics	Within one year after the randomization

External Links

•   An example of a comprehensive approach to increase the access to evidence-based tobacco cessation support for smokers with rheumatic diseases